Breaking the LSD1/KDM1A Addiction: Therapeutic Targeting of the Epigenetic Modifier in AML

被引:46
|
作者
Lokken, Alyson A. [1 ]
Zeleznik-Le, Nancy J. [1 ,2 ]
机构
[1] Loyola Univ Chicago, Inst Oncol, Maywood, IL 60153 USA
[2] Loyola Univ Chicago, Dept Med, Maywood, IL 60153 USA
关键词
LSD1; COMPLEXES; PROTEINS;
D O I
10.1016/j.ccr.2012.03.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
KDM1A/LSD1, a histone H3K4/K9 demethylase and epigenetic regulator with roles in both gene activation and repression, has increased expression in multiple cancer types. Harris et al., in this issue of Cancer Cell, and Schenk et al. show that KDM1A may be a viable therapeutic target in treating AML.
引用
收藏
页码:451 / 453
页数:3
相关论文
共 50 条
  • [41] Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation
    Ravasio, Roberto
    Ceccacci, Elena
    Nicosia, Luciano
    Hosseini, Amir
    Rossi, Pier Luigi
    Barozzi, Iros
    Fornasari, Lorenzo
    Dal Zuffo, Roberto
    Valente, Sergio
    Fioravanti, Rossella
    Mercurio, Ciro
    Varasi, Mario
    Mattevi, Andrea
    Mai, Antonello
    Pavesi, Giulio
    Bonaldi, Tiziana
    Minucci, Saverio
    SCIENCE ADVANCES, 2020, 6 (15)
  • [42] PHARMACOLOGICAL INHIBITION OF LSD1/KDM1A IN DIFFUSE MIDLINE GLIOMA MODELS AND IMPACT ON KINASE SIGNALING
    Hernandez, Faith A.
    Stitzlein, Lea M.
    Nam, Deokhwa
    Adams, Jack
    McCabe, Caitlin
    Monje, Michelle
    Waranecki, Piotr
    Hulleman, Esther
    Becher, Oren
    Chandra, Joya
    NEURO-ONCOLOGY, 2024, 26
  • [43] LSD1/KDM1A promotes hematopoietic commitment of hemangioblasts through downregulation of Etv2
    Takeuchi, Miki
    Fuse, Yuji
    Watanabe, Mana
    Andrea, Christina-Sylvia
    Takeuchi, Miho
    Nakajima, Hitomi
    Ohashi, Ken
    Kaneko, Hiroshi
    Kobayashi-Osaki, Maki
    Yamamoto, Masayuki
    Kobayashi, Makoto
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (45) : 13922 - 13927
  • [44] Cytoplasmic translocation of nuclear LSD1 (KDM1A) in human hepatoma cells is induced by its inhibitors
    Yabuta, Suemi
    Shidoji, Yoshihiro
    HEPATIC ONCOLOGY, 2019, 6 (02)
  • [45] Targeting LSD1 for acute myeloid leukemia (AML) treatment
    Zhang, Shujing
    Liu, Menghan
    Yao, Yongfang
    Yu, Bin
    Liu, Hongmin
    PHARMACOLOGICAL RESEARCH, 2021, 164
  • [46] The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer
    Kashyap, Vasundhra
    Ahmad, Shafqat
    Nilsson, Emeli M.
    Helczynski, Leszek
    Kenna, Sinead
    Persson, Jenny Liao
    Gudas, Lorraine J.
    Mongan, Nigel P.
    MOLECULAR ONCOLOGY, 2013, 7 (03) : 555 - 566
  • [47] Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc
    Nagasaka, Mai
    Tsuzuki, Kaori
    Ozeki, Yu
    Tokugawa, Muneshige
    Ohoka, Nobumichi
    Inoue, Yasumichi
    Hayashi, Hidetoshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (03) : 481 - 488
  • [48] Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma
    Wei, Xiaomu
    Calvo-Vidal, M. Nieves
    Chen, Siwei
    Wu, Gang
    Revuelta, Maria V.
    Sun, Jian
    Zhang, Jinghui
    Walsh, Michael F.
    Nichols, Kim E.
    Joseph, Vijai
    Snyder, Carrie
    Vachon, Celine M.
    Mckay, James D.
    Wang, Shu-Ping
    Jayabalan, David S.
    Jacobs, Lauren M.
    Becirovic, Dina
    Waller, Rosalie G.
    Artomov, Mykyta
    Viale, Agnes
    Patel, Jayeshkumar
    Phillip, Jude
    Chen-Kiang, Selina
    Curtin, Karen
    Salama, Mohamed
    Atanackovic, Djordje
    Niesvizky, Ruben
    Landgren, Ola
    Slager, Susan L.
    Godley, Lucy A.
    Churpek, Jane
    Garber, Judy E.
    Anderson, Kenneth C.
    Daly, Mark J.
    Roeder, Robert G.
    Dumontet, Charles
    Lynch, Henry T.
    Mullighan, Charles G.
    Camp, Nicola J.
    Offit, Kenneth
    Klein, Robert J.
    Yu, Haiyuan
    Cerchietti, Leandro
    Lipkin, Steven M.
    CANCER RESEARCH, 2018, 78 (10) : 2747 - 2759
  • [49] KDM1A/LSD1 inhibition enhances estrogen receptor beta mediated tumor suppression in ovarian cancer
    Venkata, Prabhakar P.
    Jayamohan, Sridharan
    He, Yi
    Alejo, Salvador
    Johnson, Jessica D.
    Pratap, Uday P.
    Viswanadhapalli, Suryavathi
    Weintraub, Susan
    Tekmal, Rajeshwar R.
    Vadlamudi, Ratna K.
    Kost, Edward
    Sareddy, Gangadhara R.
    CANCER RESEARCH, 2023, 83 (07)
  • [50] Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors
    Ma, Qi-Sheng
    Yao, Yongfang
    Zheng, Yi-Chao
    Feng, Siqi
    Chang, Junbiao
    Yu, Bin
    Liu, Hong-Min
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 162 : 555 - 567